90 INF-36: Medicaid Reimbursement of AZT for Foster Children
Recently the federal Food and Drug Administration approved the drug Retrovir (referred to as AZT) for use in the clinical treatment of children aged thirteen years or younger with HIV (Human Immuno-deficiency Virus) infection. The purpose of this release is to inform local departments of social services of the Department's policy regarding reimbursement for the cost of AZT.
